The Enterprise Value as of November 2025 (TTM) for Dechra Pharmaceuticals PLC (DPHAY) is 4.83B

According to Dechra Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 4.83B. This represents a change of 7.79% compared to the average of 4.48B of the last 4 quarters.

Dechra Pharmaceuticals PLC (DPHAY) Historical Enterprise Value (quarterly & annually)

How has DPHAY Enterprise Value performed in the past?

The mean historical Enterprise Value of Dechra Pharmaceuticals PLC over the last ten years is 2.69B. The current 4.83B Enterprise Value has changed 17.89% with respect to the historical average. Over the past ten years (40 quarters), DPHAY's Enterprise Value was at its highest in in the December 2021 quarter at 5.99B. The Enterprise Value was at its lowest in in the December 2003 quarter at 74.95M.

Dechra Pharmaceuticals PLC (DPHAY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dechra Pharmaceuticals PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dechra Pharmaceuticals PLC (DPHAY) Average Enterprise Value

How has DPHAY Enterprise Value performed in the past?

The current Enterprise Value of Dechra Pharmaceuticals PLC (DPHAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dechra Pharmaceuticals PLC (DPHAY) Enterprise Value vs. Peers

How is DPHAY’s Enterprise Value compared to its peers?

Dechra Pharmaceuticals PLC’s Enterprise Value is greater than McKesson Europe AG (4.78B), less than Hangzhou Tigermed Consulting Co., Ltd. (36.59B), greater than Abcam plc (134.60M), less than Mediclinic International plc (392.12B), greater than Indivior PLC (3.93B), greater than Indivior PLC (3.93B), less than Galenica AG (5.38B), less than Ascentage Pharma Group International (21.50B), less than Luye Pharma Group Ltd. (15.21B), less than Sugi Holdings Co.,Ltd. (606.93B),

Build a custom stock screener for Dechra Pharmaceuticals PLC (DPHAY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dechra Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dechra Pharmaceuticals PLC (DPHAY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dechra Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.